BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15145984)

  • 1. Hepatic secretion of small lipoprotein particles in apobec-1-/- mice is regulated by the LDL receptor.
    Nassir F; Xie Y; Patterson BW; Luo J; Davidson NO
    J Lipid Res; 2004 Sep; 45(9):1649-59. PubMed ID: 15145984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal lipoprotein assembly in apobec-1-/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins.
    Xie Y; Nassir F; Luo J; Buhman K; Davidson NO
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G735-46. PubMed ID: 12816761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression.
    Nakamuta M; Taniguchi S; Ishida BY; Kobayashi K; Chan L
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):747-55. PubMed ID: 9598833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal production rate of apolipoprotein B in LDL receptor-deficient mice.
    Millar JS; Maugeais C; Fuki IV; Rader DJ
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):989-94. PubMed ID: 12067909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
    Fu T; Mukhopadhyay D; Davidson NO; Borensztajn J
    J Biol Chem; 2004 Jul; 279(27):28662-9. PubMed ID: 15123680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying allele.
    Chen Z; Fitzgerald RL; Li G; Davidson NO; Schonfeld G
    J Lipid Res; 2004 Jan; 45(1):155-63. PubMed ID: 13130124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences.
    Johnson LA; Altenburg MK; Walzem RL; Scanga LT; Maeda N
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1745-52. PubMed ID: 18617647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.
    Nakamuta M; Chang BH; Zsigmond E; Kobayashi K; Lei H; Ishida BY; Oka K; Li E; Chan L
    J Biol Chem; 1996 Oct; 271(42):25981-8. PubMed ID: 8824235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits.
    Greeve J; Jona VK; Chowdhury NR; Horwitz MS; Chowdhury JR
    J Lipid Res; 1996 Sep; 37(9):2001-17. PubMed ID: 8895066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
    Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
    Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The low density lipoprotein receptor prevents secretion of dense apoB100-containing lipoproteins from the liver.
    Larsson SL; Skogsberg J; Björkegren J
    J Biol Chem; 2004 Jan; 279(2):831-6. PubMed ID: 14583618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the LDL receptor in apolipoprotein B secretion.
    Twisk J; Gillian-Daniel DL; Tebon A; Wang L; Barrett PH; Attie AD
    J Clin Invest; 2000 Feb; 105(4):521-32. PubMed ID: 10683382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective lowering of plasma, LDL, and esterified cholesterol in LDL receptor-knockout mice by adenovirus-mediated gene delivery of ApoB mRNA editing enzyme (Apobec1).
    Teng B; Ishida B; Forte TM; Blumenthal S; Song LZ; Gotto AM; Chan L
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):889-97. PubMed ID: 9157952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
    Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
    Oka K; Kobayashi K; Sullivan M; Martinez J; Teng BB; Ishimura-Oka K; Chan L
    J Biol Chem; 1997 Jan; 272(3):1456-60. PubMed ID: 8999814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits.
    Kozarsky KF; Bonen DK; Giannoni F; Funahashi T; Wilson JM; Davidson NO
    Hum Gene Ther; 1996 May; 7(8):943-57. PubMed ID: 8727508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone regulates hepatic triglyceride mobilization and apolipoprotein B messenger ribonucleic Acid editing in a murine model of congenital hypothyroidism.
    Mukhopadhyay D; Plateroti M; Anant S; Nassir F; Samarut J; Davidson NO
    Endocrinology; 2003 Feb; 144(2):711-9. PubMed ID: 12538634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance.
    Siri P; Candela N; Zhang YL; Ko C; Eusufzai S; Ginsberg HN; Huang LS
    J Biol Chem; 2001 Dec; 276(49):46064-72. PubMed ID: 11598138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic inactivation of murine
    Tang VT; McCormick J; Xu B; Wang Y; Fang H; Wang X; Siemieniak D; Khoriaty R; Emmer BT; Chen XW; Ginsburg D
    Elife; 2022 Oct; 11():. PubMed ID: 36193893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice.
    Foley EM; Gordts PLSM; Stanford KI; Gonzales JC; Lawrence R; Stoddard N; Esko JD
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2065-74. PubMed ID: 23846497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.